CTOs on the Move

V Shred

www.vshred.com

 
The Vinsanity Shred is a brand with many different products and online personal training and meal plans that are guaranteed to get you your dream body.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.vshred.com
  • 4530, South Decatur Boulevard
    Las Vegas, NV USA 89103
  • Phone: 800.778.7879

Executives

Name Title Contact Details
Wes Brown
Chief Technology Officer Profile

Similar Companies

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinical Reference Laboratory

Clinical Reference Laboratory was founded in 1979 under the name Enzyme Technology. Enzyme Technology placed its emphasis on modifying and patenting immunoassay techniques used in toxicology, serology, and urinalysis.

TargetRx

TargetRx is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WiserTogether

WiserTogether`s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers and providers. The company serves over 3 million people through their employers and health plans.

RRD International, LLC

Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).